Algorae Pharmaceuticals Limited (ASX:1AI)
Australia · Delayed Price · Currency is AUD 0.0120
0.00 (0.00%)
Aug 5, 2026, 3:24 PM AEST
Algorae Pharmaceuticals Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 1.13 | 0.47 | 0.81 | 2.09 | 4.24 | 1.57 |
Short-Term Investments | 0.75 | 1.85 | 2.3 | 2.02 | - | 0.04 |
Cash & Short-Term Investments | 1.88 | 2.32 | 3.11 | 4.11 | 4.24 | 1.61 |
Cash Growth | -18.80% | -25.39% | -24.39% | -3.02% | 162.92% | -45.62% |
Accounts Receivable | 0 | 0 | 0.03 | 0.01 | - | - |
Other Receivables | 0.03 | 0.04 | 0.01 | 0.09 | 0.03 | 0.01 |
Receivables | 0.03 | 0.04 | 0.04 | 0.1 | 0.03 | 0.01 |
Other Current Assets | 0.09 | 0.04 | 0.04 | - | - | - |
Total Current Assets | 2 | 2.4 | 3.19 | 4.21 | 4.27 | 1.63 |
Property, Plant & Equipment | - | - | - | 0 | 0.01 | 0.02 |
Total Assets | 2 | 2.4 | 3.19 | 4.21 | 4.27 | 1.64 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 0.08 | 0.07 | 0.12 | 0.18 | 0.05 | 0.04 |
Accrued Expenses | 0.03 | 0.1 | 0.06 | 0.27 | 0.15 | 0.22 |
Other Current Liabilities | - | - | - | - | 0.04 | - |
Total Current Liabilities | 0.11 | 0.17 | 0.18 | 0.45 | 0.24 | 0.27 |
Total Liabilities | 0.11 | 0.17 | 0.18 | 0.45 | 0.24 | 0.27 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 81.73 | 81.54 | 81.54 | 80.24 | 78.95 | 74.37 |
Retained Earnings | -80.75 | -79.89 | -79.08 | -80.73 | -78.74 | -76.79 |
Comprehensive Income & Other | 0.91 | 0.57 | 0.56 | 4.25 | 3.83 | 3.79 |
Shareholders' Equity | 1.89 | 2.23 | 3.01 | 3.76 | 4.03 | 1.38 |
Total Liabilities & Equity | 2 | 2.4 | 3.19 | 4.21 | 4.27 | 1.64 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Cash (Debt) | 1.88 | 2.32 | 3.11 | 4.11 | 4.24 | 1.61 |
Net Cash Growth | -18.80% | -25.39% | -24.39% | -3.02% | 162.92% | -40.51% |
Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Filing Date Shares Outstanding | 1,689 | 1,687 | 1,687 | 1,636 | 1,285 | 571.44 |
Total Common Shares Outstanding | 1,689 | 1,687 | 1,687 | 1,560 | 1,285 | 571.44 |
Working Capital | 1.89 | 2.23 | 3.01 | 3.76 | 4.03 | 1.36 |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tangible Book Value | 1.89 | 2.23 | 3.01 | 3.76 | 4.03 | 1.38 |
Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Machinery | - | - | - | - | 0.01 | 0.05 |